XML 22 R9.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Business Acqusition | 12 Months Ended
--- | ---
Dec. 31, 2017
Business Combinations [Abstract] |
Business Acquisition | Business Acquisition On January 4, 2016, we acquired all of the stock of SurgiQuest, Inc. ("SurgiQuest") for $257.7 million in cash (based on an aggregate purchase price of $265 million as adjusted pursuant to the merger agreement governing the acquisition). SurgiQuest developed, manufactured and marketed the AirSeal® System, the first integrated access management technology for use in laparoscopic and robotic procedures. This proprietary and differentiated access system is complementary to our current general surgery offering. The acquisition was funded through a combination of cash on hand and long-term borrowings. The following table summarizes the fair values of the assets acquired and liabilities assumed as a result of the SurgiQuest acquisition.
Cash | $ | 1,305 |
Accounts receivable | 10,032 |
Inventory | 4,267 |
Other current assets | 728 |
Current assets acquired | 16,332 |
Property, plant & equipment | 3,332 |
Goodwill | 136,687 |
Customer and distributor relationships | 76,420 |
Developed technology | 49,600 |
Trademarks and tradenames | 4,780 |
Other non-current assets | 1,553 |
Total assets acquired | $ | 288,704 |
Accounts payable | $ | 5,012 |
Other current liabilities | 6,004 |
Current liabilities assumed | 11,016 |
Deferred income taxes | 19,505 |
Other long-term liabilities | 454 |
Total liabilities assumed | 30,975 |
Net assets acquired | $ | 257,729 |
The unaudited pro forma information for the years ended December 31, 2016 and 2015, assuming SurgiQuest occurred as of January 1, 2015 are presented below. This information has been prepared for comparative purposes only and does not purport to be indicative of the results of operations which actually would have resulted had the SurgiQuest acquisition occurred on the dates indicated, or which may result in the future.
| December 31,
| 2016 |  | 2015
Net sales | $ | 763,520 |  |  | $ | 768,726 |
Net income | 29,153 |  |  | (9,673 | )
These pro forma results include certain adjustments, primarily due to increases in amortization expense due to fair value adjustments of intangible assets, increases in interest expense due to additional borrowings incurred to finance the acquisition, and acquisition related costs including transaction costs such as legal, accounting, valuation and other professional services as well as integration costs such as severance and retention. Acquisition related costs included in the determination of pro forma net income for the year ended December 31, 2015 totaled $20.6 million. Such amounts are excluded from the determination of pro forma net income for the year ended December 31, 2016. Net sales associated with SurgiQuest of $68.4 million have been recorded in the consolidated statement of comprehensive income for the year ended December 31, 2016. It is impracticable to determine the earnings recorded in the consolidated statement of comprehensive income associated with the SurgiQuest acquisition for the year ended December 31, 2016 as these amounts are not separately measured.

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -URI http://asc.fasb.org/topic&trid=2303972 + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration